At ~$57 against a $24.70 NAV, RVI's premium means you pay roughly $1.90 for $1.00 of underlying private holdings — worth it only if SpaceX, OpenAI, and Anthropic re-rate NAV faster than the premium compresses. That's the short answer. The longer answer is more interesting.
The Robinhood Ventures Fund (RVI) gave retail investors something they'd never had: a single ticker holding secondary stakes in SpaceX, OpenAI, Anthropic, Stripe, and Databricks. Demand was so intense that shares ran to nearly double the last reported net asset value within weeks of listing. The question every buyer now faces isn't "are these good companies" — it's "am I willing to pay 90% over what the fund itself says they're worth." Here's a framework to answer it honestly.
Is the RVI NAV premium worth it?
The RVI NAV premium is worth paying only if you expect the fund's net asset value to rise faster than the premium shrinks. RVI listed March 6, 2026 at $25.00 against a $24.70 NAV, then traded to about $57.02 by late May — a premium of roughly 90% to 130% depending on the day. Paying that means buying $1.00 of private holdings for nearly $1.90, before a 2.5% annual fee.
That premium is not free money the fund created — it's a price the market set for access. To decide whether it's worth it, you have to separate two distinct bets: the bet on the underlying companies (will SpaceX and OpenAI be worth more?) and the bet on the premium itself (will the market keep paying 90% over NAV, or will it revert?). Most retail buyers conflate the two. The framework below pulls them apart.
The premium math: what you actually pay above NAV
Before the framework, anchor on the numbers. Here is what RVI's premium has looked like since listing, and what each scenario does to your return if you buy at the premium and NAV stays flat:
| Scenario | Share Price | NAV | Premium | Your Return* |
|---|---|---|---|---|
| IPO day (Mar 6) | $25.00 | $24.70 | ~1% | Baseline |
| Late-May peak | $57.02 | $24.70 | ~131% | +128% (paper) |
| Premium halves | $37.05 | $24.70 | ~50% | −35% |
| Reverts to NAV | $24.70 | $24.70 | 0% | −57% |
| NAV doubles, premium gone | $49.40 | $49.40 | 0% | −13% |
| NAV doubles, 50% premium | $74.10 | $49.40 | ~50% | +30% |
*Return measured from a $57 entry. The table makes the central risk obvious: NAV can double — a spectacular outcome for the underlying companies — and you can still lose money if the premium collapses at the same time. That's the trap of buying any closed-end fund at a steep premium. You can cross-check the underlying company marks against live data on the AI valuations dashboard.
A five-question framework for whether RVI's premium is worth it
Run RVI through these five questions. If you can't answer "yes" to at least three with conviction, you're probably paying for hype rather than value.
When RVI's premium is worth it — and when it isn't
The premium is most defensible early, before the marquee holdings list publicly. In the window where SpaceX, OpenAI, and Anthropic are still private, RVI is genuinely one of the only liquid, no-accreditation ways for a retail investor to own them. That scarcity has real value, and a market clearing at 50–90% over NAV isn't irrational if you believe those three names are worth materially more than their last private marks. SpaceX's secondary valuation near $350–1,770B and Anthropic's reported $965B filing are the kind of numbers that can re-rate a NAV in a hurry.
The premium stops being worth it the moment the access advantage evaporates. As each holding goes public through 2026 and 2027, you can simply buy the stock directly — no fund, no fee, no premium. At that point RVI's structural edge shrinks to whatever private positions remain unlisted, and the historical pattern for closed-end funds is brutal: premiums fade, and many of these vehicles eventually trade at discounts to NAV. As a 3x founder who's watched plenty of "only way to get access" vehicles lose their shine, I'd weight that reversion risk heavily.
The cleanest mental model: you're buying a portfolio of pre-IPO companies and shorting the eventual normalization of the premium. Both have to work. Track the holdings' listing timelines on the Tech IPO tracker and the private-market comps on the unicorns dashboard so you're marking your own thesis, not trusting the share price to do it for you.
The premium-compression risk most retail buyers ignore
Here's the part that gets glossed over in the excitement. Closed-end funds are not ETFs — there's no creation/redemption mechanism arbitraging the price back to NAV. That's exactly why RVI can trade 90% above NAV in the first place, but it's also why nothing stops it from trading 20% below NAV later. Across the broad universe of closed-end funds, the median vehicle trades at a discount to NAV, not a premium, and the funds that launch at premiums are statistically the most likely to disappoint.
So before you buy, write down the price you'd pay if RVI traded at NAV ($24.70) and the price at a 20% discount ($19.76). If those numbers make you flinch relative to today's ~$57, you're not buying a portfolio — you're buying a premium, and premiums are the first thing to go when sentiment turns. The right time to revisit RVI may well be after the IPO wave, when the premium has normalized and you can value it on holdings alone.
The bottom line: is RVI worth the premium?
At ~$57 against a $24.70 NAV, RVI is worth its ~90%+ premium only for investors who (1) hold a genuine conviction that SpaceX, OpenAI, and Anthropic will re-rate NAV sharply higher, (2) accept a 2.5% annual fee, (3) can absorb a 30–57% drawdown if the premium reverts, and (4) size it as a small, speculative slice. For everyone else, the smarter play is patience: let the IPO wave convert the holdings to public prices, watch the premium compress, and buy the exposure — directly or through RVI at NAV — without paying nearly double for access you'll soon have anyway.